Financial Year |
March 31 2023 |
Monetary Funds |
9,827,440,888.00 |
Held-for-trading Financial Assets |
951,895,524.00 |
Notes Receivable |
133,001,611.00 |
Accounts Receivable |
2,054,368,119.00 |
Advances to Suppliers |
196,642,707.00 |
Other Receivables |
1,052,981,741.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
8,943,643.00 |
Inventories |
48,688,247.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
2,717,391.00 |
Other Current Assets |
181,996,078.00 |
Total Current Assets |
14,963,344,823.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
32,291,479.00 |
Long-term Equity Investment |
13,283,492,763.00 |
Investment Properties |
187,873,591.00 |
Fixed Assetes |
22,063,803,937.00 |
Under-construction Projects |
2,747,975,153.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
3,232,930,649.00 |
R&D expenses |
38,579,284.00 |
Goodwill |
48,683,209.00 |
Long-Term Deferred and Prepaid Expenses |
81,880,998.00 |
Deferred Income Tax Assets |
967,381,356.00 |
Other Non-Current Assets |
461,543,068.00 |
Sub-Total of Non-Current Assets |
44,163,833,755.00 |
Total Assets |
59,127,178,578.00 |
Short-Term Loans |
332,093,422.00 |
Trading Financial liabilities |
-- |
Notes Payable |
924,772,258.00 |
Accounts Payable |
1,391,796,479.00 |
Accounts Received In Advance |
3,534,550.00 |
Employee Compensation Payable |
496,520,121.00 |
Taxes Payable |
413,582,660.00 |
Interest Payable |
-- |
Dividend Payable |
52,925,793.00 |
Other payables |
3,996,440,428.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
343,900,000.00 |
Other Current Liabilities |
4,190,535.00 |
Sub-Total of Current Liabilities |
8,412,460,373.00 |
Long-term Loans |
1,818,048,018.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
363,262,037.00 |
Special Payable |
-- |
Estimatied Liabilities |
30,844,000.00 |
Deferred Income Tax Liabilities |
72,915,100.00 |
Other Non-Current Liabilities |
2,217,780,536.00 |
Sub-Total of Non-Current Liabilities |
7,915,613,368.00 |
Total Liabilities |
16,328,073,740.00 |
Paid-In Capital(Or Share Stock) |
6,491,100,000.00 |
Capital Surplus |
11,883,654,614.00 |
Surplus Reserve |
2,419,818,733.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
17,902,465,365.00 |
Minority Stockholder's Interest |
4,124,216,881.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
38,674,887,957.00 |
Owner's Equity(Stockholder's Equity) |
42,799,104,838.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
59,127,178,578.00 |